Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Review highlights shortage of data on elderly cancer patients

Publish date:: March 16, 2020

Key clinical point: Clinical trials for cancer are underreporting safety and efficacy data for elderly patients.

Major finding: Roughly 40% of articles reporting efficacy data and 9% of articles reporting safety data stratified results by age.

Study details: A systematic review of 159 articles describing phase 3 trials of chemotherapy in cancer patients.

Disclosures: The investigators disclosed no conflicts of interest.

Citation:

BrintzenhofeSzoc K et al. J Geriatr Oncol. 2020 Jan 10. pii: S1879-4068(19)30501-6.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Mixed Topics

Phase 1 study: Beta-blocker may improve melanoma treatment response,

REALITY trial supports restrictive transfusion in anemic MI,

Men occupy most leadership roles in medicine,

Study highlights benefits of integrating dermatology into oncology centers,

Tandem transplantation, long-term maintenance may extend MM remission,